CancerX shared a post on LinkedIn:
“Applications are now open for the 2026 CancerX Accelerator Cohort!
This 5-month Accelerator program (Feb–Jun 2026) has been honed with 2 years of strong track record and demonstrated success in scaling oncology startups.
Are you ready to roll up your sleeves and collaborate with leading oncology champions, including Memorial Sloan Kettering Cancer Center, Johnson and Johnson, Moffitt Cancer Center, AstraZeneca, Elevance Health, Advocate Health, Rush University System for Health, Novartis US and more, to impact the following core areas?
- Reimagining clinical trials
- Care excellence in communities
- Smart care decisions and operations
- Reducing financial toxicity
We invite you to apply here on Constellation:
Deadline: October 28, 2025
Let’s accelerate the future of oncology innovation together.”
More posts featuring CancerX.